Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Jeffrey Alan Jones | Chief Medical Officer | 2025-02-25 | 4,895 | $8.53 | $41.75kSell |
Nadim Ahmed | President and CEO | 2025-02-25 | 12,529 | $8.53 | $106.87kSell |
Jacquelyn L. Sumer | Chief Legal Officer | 2025-02-25 | 3,756 | $8.53 | $32.04kSell |
Jennifer Michaelson | Chief Scientific Officer | 2025-02-25 | 3,756 | $8.53 | $32.04kSell |
Jennifer Michaelson | Chief Scientific Officer | 2025-01-06 | 4,000 | $12.51 | $50.04kSell |
Nadim Ahmed | President and CEO | 2024-12-24 | 8,400 | $11.87 | $99.71kSell |
Jeffrey Alan Jones | Chief Medical Officer | 2024-12-18 | 4,632 | $11.41 | $52.85kSell |
Jacquelyn L. Sumer | Chief Legal Officer | 2024-12-18 | 3,482 | $11.41 | $39.73kSell |
Jennifer Michaelson | Chief Scientific Officer | 2024-12-18 | 4,693 | $11.41 | $53.55kSell |
Jennifer Michaelson | Chief Scientific Officer | 2024-12-12 | 3,489 | $12.52 | $43.68kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ansbert Gadicke | 27.61% | 16,157,644 | $127.65M | Insider |
Ubs Oncology Impact Fund LP | 13.07% | 7,648,268 | $60.42M | Insider |
Mpm Bioimpact LLC | 13.07% | 7,648,268 | $60.42M | Institution |
Bvf Inc | 9.83% | 5,750,683 | $45.43M | Institution |
Morana Jovanembiricos | 7.91% | 4,631,022 | $36.59M | Insider |
Vision Scs F2 | 7.65% | 4,476,350 | $35.36M | Insider |
F2 Bioscience I 2017 Ltd | 7.57% | 4,430,964 | $35.00M | Insider |
Blackrock Inc | 7.47% | 4,371,025 | $34.53M | Institution |
Deerfield Management Company LP Series C | 5.78% | 3,379,399 | $26.70M | Institution |
Vanguard Group Inc | 5.02% | 2,936,227 | $23.20M | Institution |